Mantra Pharma expands its commitment to bone health with the launch of Qosequ™, the company’s first biosimilar

Mantra Pharma expands its commitment to bone health with the launch of Qosequ™, the company’s first biosimilar

Read more

Mantra Pharma Announces Notice of Compliance and Launch of REDDY-Semaglutide in Quebec

Brossard, April 30, 2026 – Through its partnership with Dr. Reddy’s, Mantra Pharma is proud to be the first company to receive a Notice of Compliance (NOC) from Health Canada for REDDY-Semaglutide, a generic of Ozempic®.

Read more

mcal® expands its range with calcium citrate powder

BROSSARD, April 24, 2026 – mcal® announces the launch of mcal® Calcium Citrate Powder for Oral Suspension, a new option designed to facilitate daily calcium administration, particularly in settings where ease of use and dosing accuracy are essential.

Read more

Mantra acquires Cutimed and the Cutibase brand

BROSSARD, April 2, 2026 — Mantra Pharma is proud to announce the acquisition of the Quebec-based company Cutimed, manufacturer of the Cutibase dermatological skincare line, well known among dermatologists and pharmacists and widely distributed in pharmacies across Quebec.

Read more

Conclusion of Ulticare® Promotion by Mantra Pharma Inc.

Effective December 15, 2025, Mantra Pharma Inc. will no longer be responsible for promoting Ulticare® products on behalf of Stericycle Inc.

Read more

Mantra Pharma becomes the official representative of Dr. Reddy’s products in Quebec

Read more

New Representation Agreements for Myriad Pharma: Laboratoire Modilac and La ligne J’ARRÊTE

BROSSARD, March 17, 2025 – Myriad Pharma, the division of Mantra Pharma specializing in the marketing of over-the-counter products, is expanding its representation network with two new partners: Laboratoire Modilac and La ligne J'ARRÊTE.

Read more

Marcan Pharmaceuticals becomes shareholder of Mantra Pharma

Brossard, November 7, 2023 – Mantra Pharma, a company that develops and markets generic drugs and over-the-counter products, has taken another step to achieve its growth objectives by signing an agreement to bring in Marcan Pharmaceuticals, a Canadian pharmaceutical company, as a shareholder.

Read more

Mantra Pharma Introduces the First Generic Alternative to CLAVULIN® (GSK) in Canada

BROSSARD, December 16, 2022 - Following an increase in cases of respiratory viruses, Canada is currently experiencing supply issues for an oral antibiotic for children, the CLAVULIN® from GSK. This shortage is being alleviated by the arrival of the very first generic drug from a Quebec company: M-Amoxi Clav offered by Mantra Pharma.

Read more

Mantra Pharma opens its new distribution centre

LÉVIS, 10 January, 2021 - It is with great pride that Mantra Pharma’s Lévis team opened its new warehouse and business location The building already spreads out over 35,000 square feet and hosts 25 employees.

Read more